NCI-MATCH: Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors or Lymphomas
Study Number: 

NCG 275215 Z1D

Phase: 
2
Trial categories: 
Advanced Solid Tumor
Immunotherapy
Antibody therapy
Checkpoint blockade
Principal Investigator: